PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells

By          

International Journal of Oncology, Vol. 42, Iss. 2, 2013-01 ,pp. : 419-428

Spandidos Publications

Access to resources Recommend Favorite

Multiple copies of BCR-ABL fusion gene on two isodicentric Philadelphia chromosomes in an imatinib mesylateresistant chronic myeloid leukemia patient

By          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1579-1582

Spandidos Publications

Access to resources Recommend Favorite

Trichosanthin down-regulated p210^Bcr-Abl and enhanced imatinib-induced growth arrest in chronic myelogenous leukemia cell line K562

By Zhang Kunzhong   Xu Jianhua   Huang Xiuwang   Wu Lixian   Wen Caixia   Hu Yingying   Su Yu   Chen Yuanzhong   Zhang Zhiqiang  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 581-587

Springer Publishing Company

Access to resources Recommend Favorite

CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation

By                    

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 253-261

Spandidos Publications

Access to resources Recommend Favorite

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate

By Hardling Mats   Wei Yuan   Palmqvist Lars   Swolin Birgitta   Stockelberg Dick   Gustavsson Bengt   Ekeland-Sjöberg Kerstin   Wadenvik Hans   Ricksten Anne  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 349-358

Humana Press, Inc

Access to resources Recommend Favorite